Dr Elvira van Dalen, MD PhD, is a senior clinical scientist / epidemiologist and works at the Systematic Review & Guideline Unit of the Princess Máxima Center for Pediatric Oncology, Utrecht, NL. She also is one of the coordinators of the International Late Effects of Childhood Cancer Guideline Harmonisation Group (IGHG).
She did her PhD thesis on anthracycline-induced cardiotoxicity during and after treatment for childhood cancer. Her main research interests are late effects after treatment for childhood cancer, with a special focus on cardiovascular disease and systematic reviews and guidelines in the field of pediatric oncology. She has co-authored over 100 articles in peer-reviewed journals and several book chapters. She is involved in multiple (inter)national studies on cardiotoxicity during and after childhood cancer treatment and in many (inter)national guidelines in collaboration with, among others, the IGHG and the pan-European PanCare network.
